Table 3.
Malaria diagnostic and treatment practices for febrile patients at all 244 surveyed facilities in Sudan
| Children < 5 yrs N = 425 | Patients ≥ 5 yrs N = 1218 | P-value | All age groups N = 1643 |
||
|---|---|---|---|---|---|
| n (%) | n (%) | n (%) | 95% CI | ||
| Correctly manageda | 150 (35.3) | 417 (34.2) | 0.723 | 567 (34.5) | 29.3-39.7 |
| Malaria test performed | 186 (43.8) | 566 (46.5) | 0.425 | 752 (45.8) | 39.0-52.6 |
| Treatment for test positive patients | N = 72 | N = 231 | N = 303 | ||
| AS+SP | 51 (70.8) | 139 (60.2) | 0.116 | 190 (62.7) | 55.6-69.9 |
| Artemether injection | 12 (16.7) | 66 (28.6) | 0.056 | 78 (25.7) | 19.6-31.8 |
| Other antimalarialsb | 4 (5.6) | 10 (4.3) | 0.754 | 14 (4.6) | 1.1-8.2 |
| No AM prescribed | 5 (6.9) | 16 (6.9) | 0.995 | 21 (6.9) | 3.5-10.4 |
| Treatment for test negative patients | N = 114 | N = 335 | N = 449 | ||
| AS+SP | 11 (9.6) | 46 (13.7) | 0.303 | 57 (12.7) | 6.3-17.7 |
| Artemether injection | 3 (2.6) | 8 (2.4) | 0.874 | 11 (2.5) | 1.0-3.9 |
| Other antimalarialsc | 1 (0.9) | 3 (0.9) | 0.986 | 4 (0.9) | 0-1.7 |
| Any AM prescribed | 15 (13.2) | 57 (17.0) | 0.336 | 72 (16.0) | 9.3-21.3 |
| No AM prescribed | 99 (86.8) | 278 (83.0) | 0.336 | 377 (84.0) | 77.9-90.0 |
| Treatment when test not done | N = 239 | N = 652 | N = 891 | ||
| AS+SP | 40 (16.7) | 193 (29.6) | 0.002 | 233 (26.2) | 19.5-32.8 |
| Artemether injection | 4 (1.7) | 32 (4.9) | 0.049 | 36 (4.0) | 1.7-6.3 |
| Other antimalarialsd | 6 (2.5) | 11 (1.7) | 0.251 | 17 (1.9) | 0.6-3.2 |
| No AM prescribed | 189 (79.1) | 416 (63.8) | 0.001 | 605 (67.9) | 60.9-74.9 |
aDefined as performance of all of the following three tasks: 1) patient tested for malaria; 2) if positive test result treated with AS+SP, and 3) if negative test result not treated for malaria.
bOther antimalarial treatments include: SP (5), QN (5) and AL (4)
cOther antimalarial treatments include: SP (3), QN (1)
dOther antimalarial treatments include: SP (5), QN (7) and CQ (5)